Workflow
独立董事任职资格审查
icon
Search documents
依米康: 第五届董事会提名委员会关于独立董事候选人任职资格的审查意见
Zheng Quan Zhi Xing· 2025-05-20 11:23
Core Points - The Nomination Committee of Yimikang Technology Group Co., Ltd. has reviewed the qualifications of independent director candidates for the sixth board of directors [1][2] - The candidates, Ms. Jiang Yumei and Mr. Zhao Mingchuan, meet the independence and qualification requirements as per relevant laws and regulations [1][2] - The committee unanimously agrees to nominate the candidates for the independent director positions and will submit this proposal to the board for review [2] Summary by Sections - **Independent Director Qualifications** - The candidates possess the necessary experience and business capabilities to fulfill the role of independent directors [2] - There are no legal or regulatory disqualifications preventing them from serving as independent directors [2] - The candidates have not been subject to any penalties or sanctions from the China Securities Regulatory Commission or the Shenzhen Stock Exchange [2] - **Nomination Committee's Conclusion** - The Nomination Committee unanimously supports the nomination of Ms. Jiang Yumei and Mr. Zhao Mingchuan as independent director candidates for the sixth board of directors [2]
南京医药: 南京医药董事会提名与人力资源规划委员会关于第十届董事会独立董事候选人任职资格的审查意见
Zheng Quan Zhi Xing· 2025-05-09 09:35
Core Viewpoint - The Nomination and Human Resources Planning Committee of Nanjing Pharmaceutical Co., Ltd. has reviewed the qualifications of independent director candidates for the 10th Board of Directors and found them to meet the necessary legal and regulatory requirements [1][2]. Summary by Relevant Sections - The committee has evaluated the personal resumes and relevant materials of candidates Wang Chunhui, Lu Yindi, and Lü Wei, confirming that they possess the necessary educational background, work experience, and business capabilities to fulfill the responsibilities of independent directors [1]. - All candidates have participated in qualification training organized by the stock exchange and obtained the necessary certificates, demonstrating their understanding of the basic knowledge required for listed company operations [1]. - The independent director candidates do not hold shares in the company and have no other relationships with the company's directors, supervisors, senior management, or shareholders holding more than 5%, ensuring their independence [1]. - The candidates have not been subject to any disqualifications as per the Company Law, nor have they been banned from the securities market by the China Securities Regulatory Commission [1]. - The Nomination and Human Resources Planning Committee has agreed to nominate Wang Chunhui, Lu Yindi, and Lü Wei as independent director candidates for the 10th Board of Directors, to be submitted for the board's review [2].
大博医疗: 第三届董事会提名委员会关于独立董事候选人任职资格的审查意见
Zheng Quan Zhi Xing· 2025-03-24 09:12
《深圳证券交易所上市公司自 律监管指引第 1 号——主板上市公司规范运作》等相关法律法规及《公司章程》 等有关规定,大博医疗科技股份有限公司(以下简称"公司")第三届董事会提 名委员会对公司第三届董事会独立董事候选人的任职资格进行了审核,并发表审 查意见如下: 经审阅独立董事候选人魏志华先生、林红珍女士提供的相关资料,我们认为: 一、截至目前,上述独立董事候选人未持有公司股份,与持有公司 5%以上 股份的股东、实际控制人、公司其他董事、监事、高级管理人员不存在关联关系; 上述独立董事候选人未受过中国证监会及其他有关部门的处罚和证券交易所纪 律处分;不存在因涉嫌犯罪被司法机关立案侦查或者涉嫌违法违规被中国证监会 立案稽查,尚未有明确结论的情形;不存在《深圳证券交易所上市公司自律监管 指引第 1 号——主板上市公司规范运作》第 3.2.2 条规定的不得提名为董事的情 形。上述独立董事候选人符合《公司法》等相关法律、法规和规范性文件及《公 司章程》规定的任职条件。 大博医疗: 第三届董事会提名委员会关于独立董事 候选人任职资格的审查意见 证券代码:002901 证券简称:大博医疗 大博医疗科技股份有限公司 第三届董 ...